CGRP Inhibitors

CGRP inhibitors are medications designed to prevent migraines by targeting a specific molecule called calcitonin gene-related peptide (CGRP), which plays a key role in migraine development. During a migraine, CGRP levels increase, causing blood vessels to dilate and pain signals to intensify. These drugs block CGRP or its receptors, reducing the frequency and severity of migraines. They are usually prescribed for people with frequent or severe migraines when other treatments aren’t effective. CGRP inhibitors are generally well-tolerated and represent a targeted approach to migraine prevention, addressing the root causes rather than just alleviating symptoms.